HSP90AB1 and cancer: In myotubes in vitro, the silencing of Hsp90 or STAT3 protects from the atrophy induced by C26 cancer cell conditional media (C26‐CM) and decreases the expression of Atrogin‐1, Myostatin and MuRF1.